33 results
8-K
EX-10.2
TNFA
TNF Pharmaceuticals Inc.
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
relating to the revocation or modification of any such certificate, authorization or permit. There is no agreement, commitment, judgment, injunction … that, except as set forth in this Agreement, no Buyer has made any commitment or promise or has any other obligation to provide any financing
8-K
EX-10.1
TNFA
TNF Pharmaceuticals Inc.
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
, authorization or permit. There is no agreement, commitment, judgment, injunction, order or decree binding upon the Company or any of its Subsidiaries … that, except as set forth in this Agreement, no Buyer has made any commitment or promise or has any other obligation to provide any financing
424B5
TNFA
TNF Pharmaceuticals Inc.
17 Aug 22
Prospectus supplement for primary offering
3:00pm
and prospective investors. The securities purchase agreement does not give rise to any commitment by the placement agent to purchase any of our shares … and manufacturing Cystron’s COVID-19 vaccine candidate to Oravax (the “Contribution Transaction”). In consideration for the Company’s commitment
8-K
EX-99.1
olnb4v5fnyemx2fv6q4
26 Oct 21
Regulation FD Disclosure
11:00am
424B3
l4k8wkn5omo39he5
11 May 21
Prospectus supplement
4:27pm
8-K
guvygmu1ny4 tv
21 Apr 21
Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger
9:56pm
8-K
usf35h6m0j 7r
19 Mar 21
Entry into a Material Definitive Agreement
5:26pm
S-4/A
ca2wudws8dqw9vkp
19 Mar 21
Registration of securities issued in business combination transactions (amended)
2:01pm
S-4
06p39c4gxi2rkcco4
15 Jan 21
Registration of securities issued in business combination transactions
5:24pm